Compounded Zepbound Online: What You're Actually Buying

Best Zepbound compounding pharmacy: 7 providers compared

None of these seven programs sells anything called Zepbound. Each one sells compounded tirzepatide. How clearly a program says so is part of what makes it worth your money.

• Lowest price: Eden, about $130 a month at every dose.
• Cheapest first month: Mochi Health, about $90.
• Most support: Fridays, with a dietitian and coaching in the price.
• Rather take a pill: Curex, about $250 a month at the starting dose. Henry Meds and Willow sell one too.
• With insurance: no insurer pays for compounded tirzepatide. Brand Zepbound is the only path, covered in our Zepbound insurance guide.

Curex: no membership, clearly labeled

Curex puts the online visit, the medicine and free shipping in one price, with no membership fee. Its "from $199" headline needs a year paid upfront, at the lowest dose. Month to month, the tablet costs about $250 and the shot about $300 at the starting dose, and about $100 more at higher doses. You can take it as a weekly shot or as a daily tablet that dissolves under the tongue. Curex says its clinicians may order labs, and labs are not covered by the plan. Its site states that Zepbound and Mounjaro belong to Eli Lilly and that Curex does not supply them. That is the kind of clear labeling worth looking for.

• Pros: no membership fee; shot or tablet; labels its product as compounded tirzepatide, not Zepbound.
• Cons: the low price needs a year paid upfront; labs cost extra; a small Trustpilot base of about 100 reviews, many from its older allergy business.

Mochi Health: cheapest first month, price rises with the dose

Mochi prices compounded tirzepatide by dose. The medicine runs about $90 to $200 a month. A $79 monthly membership comes on top and covers your clinician care. New members get the first month of membership free in most states, so month one starts at about $90. After that, expect about $170 a month at the lowest dose. At the top dose, it's about $280. Prepaying a year of membership brings the lowest dose to about $140 a month. Mochi keeps its brand-name Zepbound page and its compounded tirzepatide page apart, so the two are easy to tell apart. Lilly sued Mochi in April 2025 over how it marketed compounded tirzepatide.

• Pros: cheapest first month; board-certified providers, some certified in obesity medicine; brand and compounded offers kept separate; Trustpilot 4.5 on about 19,500 reviews.
• Cons: the price rises with your dose; the $79 membership adds to every month after the first; labs are not included.

Eden: lowest price, the same at every dose

Eden has the lowest price here, about $130 a month. That one price covers the medicine and your care. It stays the same at every dose, with no membership and no prepay. In June 2026, the FDA sent Eden a warning letter about its marketing. Its website showed vials labeled with Eden's name, although Eden had not compounded them. The Better Business Bureau rates Eden F, mostly over billing and cancellation complaints.

• Pros: lowest price on this page; the price never climbs with your dose; no membership fee; Trustpilot 4.5 on about 4,900 reviews.
• Cons: an FDA warning letter in June 2026; a BBB rating of F, with most complaints unanswered; its terms still describe a membership the checkout no longer charges.

Peak Wellness: watch the plan length

Peak Wellness charges one price at every dose, with no membership fee. What changes the price is how long you sign up for. The first month costs about $280. After that, month to month costs about $350. A 3-month plan costs about $280 a month, paid upfront. A 6-month plan brings it to about $230 a month, also paid upfront. Peak lists no annual plan. Peak says its tirzepatide is compounded with glycine, an added amino acid. Budget for the price you'll pay every month, not the first month.

• Pros: one price at every dose; no membership fee; free next-day shipping.
• Cons: about $350 a month month to month after the first month; the lowest price needs a 6-month prepay; a small Trustpilot base of about 50 reviews.

Fridays: coaching and a dietitian included

Fridays sells compounded tirzepatide as a full program, not a bare prescription. It costs about $240 a month on a 12-month plan paid upfront. Month to month, it costs about $390. Both prices include provider visits, a one-on-one dietitian, group coaching and a fitness app. Fridays also sells a low-dose microdosing plan for about $200 a month. It markets that plan for energy and metabolic balance, not weight loss. If you'd pay for coaching anyway, the bundle is worth more than the price suggests.

• Pros: dietitian, coaching and app included; a lower monthly price on the 12-month plan; Trustpilot 4.1 on about 4,750 reviews.
• Cons: the best price needs a year paid upfront, and fees aren't refunded if you cancel mid-plan; a BBB rating of F, with 59 of 67 complaints unanswered.

Willow: from about $400 in 36 states

Willow keeps the bill simple. One monthly charge covers telehealth and shipping, with no membership. The shot costs about $400 a month at the starting doses. It climbs to about $550 at the top dose. A daily tablet costs about $400 a month, or about $460 at its highest dose. Willow serves only 36 states, so check its list before you start the intake form.

Eli Lilly sued Willow in April 2025 over its marketing. A federal judge dismissed that case in February 2026, and Lilly has appealed. Separately, the National Advertising Division, an industry watchdog, referred Willow to the FTC in December 2025 over its weight-loss claims. Willow dropped those claims in July 2026.

• Pros: one all-in bill; no membership fee; shot or tablet; LegitScript certified, an independent legal and safety check.
• Cons: only 36 states; the price climbs with the dose; no labs included; Trustpilot 3.9, lower than most programs here.

Henry Meds: tablet only, and clear that it isn't Zepbound

Henry Meds sells compounded tirzepatide only as a tablet that dissolves in the mouth. It costs about $350 a month, billed as a 3-month supply. Paying for the 3 months in full brings it to about $300 a month. Visits, supplies and shipping are included. Henry sells no brand-name GLP-1s, so its tablet can't be mistaken for Zepbound. Lilly's April 2025 suit accuses Henry of selling tirzepatide as a pill, a form the FDA has never approved. That case is still open.

• Pros: visits, supplies and shipping in one price; no needle; no membership fee; Trustpilot 4.4 on about 12,500 reviews.
• Cons: no tirzepatide shot; billed every 3 months, not month to month; Lilly's lawsuit against it is still open.

Can you buy compounded Zepbound online?

No, not under that name. Zepbound is Eli Lilly's brand name for its tirzepatide shot. The FDA approved it in 2023 for weight management. A brand name covers one exact finished product, made Lilly's way. A compounding pharmacy can't copy that product and sell it as Zepbound. What a licensed pharmacy can do is make tirzepatide itself, the active ingredient, for one patient's prescription. So an ad for compounded Zepbound is using the wrong name for a different product: compounded tirzepatide.

Lilly has gone to court over that loose language. In April 2025, it sued four telehealth companies: Mochi Health, Willow, Henry Meds and Fella Health. The suits claim false advertising under the Lanham Act, the federal law on misleading marketing. Lilly says the companies traded on its brands while selling mass-made compounded tirzepatide as personalized. The suits are about marketing, not about whether the medicine is real tirzepatide. A judge dismissed the Willow case in February 2026, and Lilly has appealed.

• Zepbound is Eli Lilly's FDA-approved, trademarked brand of tirzepatide, approved in 2023.
• Compounded tirzepatide is the same active molecule, mixed by a pharmacy under its generic name. Legally, it isn't Zepbound and can't be sold as Zepbound.
• Lilly's April 2025 lawsuits target how four telehealth companies marketed compounded tirzepatide, not whether the drug is genuine.
• A seller that says "compounded Zepbound" instead of "compounded tirzepatide" is using the wrong name. Treat that as a warning sign, not a detail.

Is compounded tirzepatide legal right now?

Yes, but on narrower ground than during the shortage. The FDA took tirzepatide off its drug shortage list in December 2024. That ended the shortage rules that let pharmacies make it in large batches. State-licensed 503A pharmacies, the kind that fill one patient's prescription at a time, had until February 18, 2025 to stop making copies. Large 503B outsourcing facilities, which make big batches, had until March 19, 2025. A federal court declined to block those deadlines.

What remains legal is compounding for one named patient at a 503A pharmacy. Under federal law, these pharmacies can't routinely make copies of an approved drug. A compounded version has to differ in a way the prescriber says matters for that patient. One example is leaving out an ingredient she's allergic to. Lower cost alone doesn't count as that reason. Lilly argues this rule is why many sellers add vitamins or other ingredients and call the result personalized.

One more change is pending. On April 30, 2026, the FDA proposed not to add tirzepatide to the list of bulk ingredients that 503B facilities may use. The comment period was extended to July 30, 2026. No final decision has been published as of October 2026. The proposal doesn't change the rules for 503A pharmacies.

• 503B large-batch compounding: ended March 19, 2025.
• 503A compounding for one patient: still legal when a prescriber documents a medical reason.
• Saving money: not a valid medical reason under FDA rules.
• The April 2026 FDA proposal: covers 503B facilities only. Comments closed July 30, 2026, and there's no final decision yet.

What compounded tirzepatide costs vs. the Zepbound brand price

Zepbound's list price, with no program at all, is about $1,085 a month. Almost no one pays it. Lilly's self-pay price brings Zepbound down to about $300 to $450 a month, depending on the dose. It covers vials from LillyDirect and, since March 16, 2026, the KwikPen at many local pharmacies. On Medicare, people who qualify for the GLP-1 Bridge can get the Zepbound KwikPen for $50 a month through Dec 31, 2027.

Compounded tirzepatide runs about $130 to $550 a month across the seven programs above. Eden and Mochi cost less than Lilly's self-pay price at every dose. Curex's tablet starts below it, and its shot starts at about the same price. Peak Wellness, Willow, Henry and Fridays month to month all cost more than Zepbound's $299 starting dose. The Zepbound dosage guide shows the usual dose steps, which drive both prices.

• Lilly self-pay, by dose: about $300 at 2.5 mg · About $400 at 5 mg · About $450 from 7.5 mg through 15 mg
• The 45-day rule: from 7.5 mg, Lilly's price holds only if you refill within 45 days · Late refills cost about $500 at 7.5 mg and about $700 from 10 mg
• Offer limits: Lilly's current self-pay terms end Dec 31, 2026 · The KwikPen offer covers up to 11 fills a year
• Zepbound self-pay, first year: about $5,100 staying at 5 mg · About $5,650 moving to 7.5 mg or higher · Both count 13 four-week fills
• Compounded tirzepatide, full year: about $1,550 at Eden · Up to about $6,600 at Willow's top dose
• Zepbound at list price: about $14,100 a year

For most people, the big gap isn't compounded versus Lilly's self-pay price. At the higher doses, those two sit close together. The big gap is either one versus list price, which costs thousands more over a year.

Compounded tirzepatide vs. Zepbound: what's actually different

Zepbound went through FDA review as a finished drug. The FDA checked Lilly's manufacturing, sterility and dose consistency before approving it. Compounded tirzepatide is made by a state-licensed pharmacy under state pharmacy law. No agency reviews the finished compounded product for safety, quality or consistency before it reaches you.

Some compounded formulas also add ingredients Zepbound doesn't contain, such as vitamin B12, glycine or L-carnitine. In a March 2026 open letter, Lilly says its tests of tirzepatide mixed with B12 found a new impurity formed when the two react. The same letter says Lilly keeps finding bacterial contamination and high endotoxin levels in compounded tirzepatide. Endotoxins are bits of bacteria that can cause fever. Lilly sells Zepbound, so it has a stake in these findings. Still, no one has studied these add-ins together with tirzepatide. Our guide to tirzepatide with B12 covers that mix in more detail.

• Regulatory review: Zepbound is FDA-reviewed as a finished drug. Compounded tirzepatide isn't; a state-licensed pharmacy makes it.
• Formats: Zepbound comes as a single-dose pen, a KwikPen or a vial, all injected. Compounded tirzepatide is usually a shot, and a few programs sell a dissolving tablet.
• Add-ins: Zepbound has no added vitamins or amino acids. Compounded versions sometimes add B12, glycine or L-carnitine.
• Insurance and savings cards: insurance can cover Zepbound, and Lilly's savings card works with it. Compounded tirzepatide is cash-pay only, though an HSA or FSA card often works.

How to find a legitimate Zepbound compounding pharmacy near you

A search for a Zepbound compounding pharmacy near you mostly turns up telehealth sign-up pages, not a shop you can walk into. That's because most compounded tirzepatide now comes through national telehealth programs. You fill in an online form, and a licensed clinician reviews it and writes the prescription. A partner 503A pharmacy, often in another state, then makes the medicine and ships it to you. Some local compounding pharmacies will also fill a tirzepatide prescription from your own doctor. Our page on compounded tirzepatide near you covers that route.

Either way, a few questions separate a legitimate program from one that cuts corners.

• Ask which pharmacy fills the prescription. A legitimate program names it, not just its own brand.
• Look for PCAB accreditation or a clean state board record. PCAB is an independent quality check for compounding pharmacies. It isn't required, but it's a good sign.
• Make sure a real clinical review happens. That means your health history and a documented reason for compounding, not a checkbox form anyone passes.
• Read what's being sold. The label should say compounded tirzepatide, not compounded Zepbound or a loose "Zepbound alternative."
• Never skip the prescription. A site that sells tirzepatide with no clinician review isn't operating legally.

Red flags: how to spot a provider falsely selling compounded Zepbound

The programs on this page name what they sell as tirzepatide, not Zepbound. A seller that uses Zepbound as the name of its own product is showing you how loosely it treats facts.

• "Compounded Zepbound" as a product name. A seller explaining the difference is fine. A seller naming its product that way is misusing a trademark.
• "Same as Zepbound" or "FDA-approved" claims. The active ingredient may be the same molecule, but the compounded product isn't FDA-approved.
• No prescription or clinician review. Walk away, whatever the price.
• No named pharmacy. A legitimate program can tell you which licensed pharmacy fills your prescription.
• Unusual payment requests. Venmo, Zelle, cash apps or crypto instead of a normal card payment.
• A price that doesn't add up. The lowest regular price among the programs above is about $130 a month. A much lower offer deserves extra questions about the pharmacy and the prescription.

Is compounded tirzepatide worth it in perimenopause, or is brand Zepbound the better call?

Midlife weight gain is common, and it isn't about willpower. As estrogen falls, fat tends to shift toward the belly. Tirzepatide acts on two gut hormones, GLP-1 and GIP. In a head-to-head trial, brand tirzepatide led to more weight loss than brand semaglutide. Those results come from Lilly's own product. No trial has tested compounded versions.

Brand Zepbound gives you FDA-reviewed manufacturing. At the higher doses, Lilly's self-pay price is close to many compounded programs, as long as you refill on time. Compounded tirzepatide makes sense if cost is your main limit or you want a tablet. In that case, confirm the pharmacy and the clinical review before you sign up. Check too that your chart records a reason beyond price. Either way, the medicine works best as one part of a wider plan for midlife weight.